A Phase II Study of Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Epithelial Ovarian/Fallopian Tube/ Primary Peritoneal Carcinoma.
Phase of Trial: Phase II
Latest Information Update: 25 Feb 2015
At a glance
- Drugs Gemcitabine (Primary) ; Vinorelbine (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 17 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 22 Feb 2012 Actual initiation date (January 2011) added as reported by ClinicalTrials.gov.